{"id":10302,"date":"2026-09-09T13:10:09","date_gmt":"2026-09-09T13:10:09","guid":{"rendered":"https:\/\/europepharmacy.eu\/?post_type=product&#038;p=10302"},"modified":"2026-09-09T13:13:10","modified_gmt":"2026-09-09T13:13:10","slug":"retatrutide-40mg","status":"publish","type":"product","link":"https:\/\/europepharmacy.eu\/it\/shop\/retatrutide-40mg\/","title":{"rendered":"Retatrutide 40MG"},"content":{"rendered":"<h1><a href=\"http:\/\/google.com\">Retatrutide 40MG<\/a><\/h1>\n<div class=\"prose break-words dark:prose-invert prose-p:leading-relaxed prose-pre:p-0 fix-max-with-100 prose-p:!mt-0\">\n<p class=\"mb-2 last:mb-0\"><a href=\"https:\/\/oroviabiolab.com\/\">Retatrutide<\/a> is an investigational triple-agonist drug (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly for obesity and type 2 diabetes management. It&#8217;s still in clinical trials (Phase 3 as of late 2024) and\u00a0<strong>not FDA-approved or commercially available<\/strong>\u00a0in any dosage, including 40 mg. Here&#8217;s a breakdown based on available data:<\/p>\n<h3>Key Facts from Clinical Trials<\/h3>\n<ul>\n<li><strong>Doses Tested<\/strong>: Highest doses in trials like TRIUMPH (Phase 3) reach up to\u00a0<strong>12 mg weekly<\/strong>\u00a0subcutaneous injection. A 40 mg dose far exceeds this and isn&#8217;t documented in any published studies\u2014likely unsafe or untested.<\/li>\n<li><strong>Efficacia<\/strong>\u00a0(from Phase 2 trials, e.g., NEJM 2023):<\/li>\n<\/ul>\n<\/div>\n<div class=\"overflow-x-auto my-4\">\n<table class=\"markdown-table\">\n<thead>\n<tr>\n<th>Dose (weekly)<\/th>\n<th>Weight Loss at 48 Weeks (vs. placebo)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1 mg<\/td>\n<td>~8-10%<\/td>\n<\/tr>\n<tr>\n<td>4 mg<\/td>\n<td>~17%<\/td>\n<\/tr>\n<tr>\n<td>8 mg<\/td>\n<td>~22-24%<\/td>\n<\/tr>\n<tr>\n<td>12 mg<\/td>\n<td>~24% (up to 30% in some subgroups)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"prose break-words dark:prose-invert prose-p:leading-relaxed prose-pre:p-0 fix-max-with-100 prose-p:!mt-0\">\n<ul>\n<li><strong>Meccanismo<\/strong>: Mimics gut hormones to reduce appetite, slow gastric emptying, boost insulin, and increase energy expenditure via glucagon.<\/li>\n<li><strong>Effetti Collaterali<\/strong>\u00a0(common, dose-dependent): Nausea (up to 50% at high doses), vomiting, diarrhea, constipation. Rare: Pancreatitis, gallbladder issues, heart rate increase (~5-10 bpm).<\/li>\n<li><strong>Stato<\/strong>: Expected approval ~2026-2027 if trials succeed. Not available via prescription.<\/li>\n<\/ul>\n<h3>Warnings on 40 mg<\/h3>\n<ul>\n<li><strong>No Legitimate Source<\/strong>: Claims of &#8220;40 mg Retatrutide&#8221; online are almost certainly counterfeit, mislabeled research chemicals, or scams from unregulated sites (e.g., China-based vendors). These could contain impurities, incorrect peptides, or nothing at all.<\/li>\n<li><strong>Risks of High\/Unauthorized Doses<\/strong>:<\/li>\n<\/ul>\n<\/div>\n<div class=\"overflow-x-auto my-4\">\n<table class=\"markdown-table\">\n<thead>\n<tr>\n<th>Potential Issue<\/th>\n<th>Why Dangerous at 40 mg<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Overdose\/Acute Toxicity<\/td>\n<td>Severe GI distress, dehydration, hypotension<\/td>\n<\/tr>\n<tr>\n<td>Receptor Overstimulation<\/td>\n<td>Tachycardia, hyperglucagonemia<\/td>\n<\/tr>\n<tr>\n<td>Contaminants<\/td>\n<td>Bacterial endotoxins, heavy metals<\/td>\n<\/tr>\n<tr>\n<td>Interazioni<\/td>\n<td>Amplifies risks with insulin\/oral meds<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"prose break-words dark:prose-invert prose-p:leading-relaxed prose-pre:p-0 fix-max-with-100 prose-p:!mt-0\">\n<ul>\n<li>Real-world reports (e.g., Reddit, forums) of &#8220;high-dose&#8221; retatrutide often involve bunk product causing hospitalizations.<\/li>\n<\/ul>\n<h3>Legit Alternatives (Approved)<\/h3>\n<\/div>\n<div class=\"overflow-x-auto my-4\">\n<table class=\"markdown-table\">\n<thead>\n<tr>\n<th>Farmaco<\/th>\n<th>Max Weekly Dose<\/th>\n<th>Weight Loss (1 year)<\/th>\n<th>Note<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Semaglutide (Wegovy\/Ozempic)<\/td>\n<td>2,4 mg<\/td>\n<td>15-20%<\/td>\n<td>Widely available<\/td>\n<\/tr>\n<tr>\n<td>Tirzepatide (Mounjaro\/Zepbound)<\/td>\n<td>15 mg<\/td>\n<td>20-25%<\/td>\n<td>Dual-agonist, closest analog<\/td>\n<\/tr>\n<tr>\n<td>Liraglutide (Saxenda)<\/td>\n<td>3 mg daily<\/td>\n<td>5-10%<\/td>\n<td>Older option<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"prose break-words dark:prose-invert prose-p:leading-relaxed prose-pre:p-0 fix-max-with-100 prose-p:!mt-0\">\n<p class=\"mb-2 last:mb-0\"><strong>Advice<\/strong>: Do not buy or use unapproved Retatrutide\u2014it&#8217;s illegal in most places without research authorization and poses serious health risks. Consult a doctor for obesity treatments. Trials recruit via clinicaltrials.gov (search &#8220;retatrutide&#8221;). Sources: Lilly press releases, NEJM publications, FDA trial database.<\/p>\n<\/div>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div>","protected":false},"excerpt":{"rendered":"<p>Retatrutide 40MG Retatrutide is an investigational triple-agonist drug (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly for obesity and type 2 diabetes management. It&#8217;s still in clinical trials (Phase 3 as of late 2024) and\u00a0not FDA-approved or commercially available\u00a0in any dosage, including 40 mg. Here&#8217;s a breakdown based on available data: Key Facts &hellip; <a href=\"https:\/\/europepharmacy.eu\/it\/shop\/retatrutide-40mg\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Retatrutide 40MG<\/span><\/a><\/p>","protected":false},"featured_media":10366,"comment_status":"open","ping_status":"closed","template":"","meta":{"postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""}},"product_brand":[],"product_cat":[793],"product_tag":[798],"class_list":["post-10302","product","type-product","status-publish","has-post-thumbnail","product_cat-accessories","product_tag-retatrutide-40mg","instock","shipping-taxable","purchasable","product-type-simple"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.5 (Yoast SEO v28.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Retatrutide 40MG<\/title>\n<meta name=\"description\" content=\"Retatrutide 40MG Retatrutide is an investigational triple-agonist drug (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly for obesity\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/europepharmacy.eu\/it\/shop\/retatrutide-40mg\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Retatrutide 40MG\" \/>\n<meta property=\"og:description\" content=\"Retatrutide 40MG Retatrutide is an investigational triple-agonist drug (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly for obesity\" \/>\n<meta property=\"og:url\" content=\"https:\/\/europepharmacy.eu\/it\/shop\/retatrutide-40mg\/\" \/>\n<meta property=\"og:site_name\" content=\"European Pharmacy\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-09T13:13:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/04\/photo_5123147599421574210_x.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"740\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/retatrutide-40mg\\\/\",\"url\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/retatrutide-40mg\\\/\",\"name\":\"Retatrutide 40MG\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/retatrutide-40mg\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/retatrutide-40mg\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/europepharmacy.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/photo_5051033548038540506_x-1-1.jpg\",\"datePublished\":\"2026-09-09T13:10:09+00:00\",\"dateModified\":\"2026-09-09T13:13:10+00:00\",\"description\":\"Retatrutide 40MG Retatrutide is an investigational triple-agonist drug (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly for obesity\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/retatrutide-40mg\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/retatrutide-40mg\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/retatrutide-40mg\\\/#primaryimage\",\"url\":\"https:\\\/\\\/europepharmacy.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/photo_5051033548038540506_x-1-1.jpg\",\"contentUrl\":\"https:\\\/\\\/europepharmacy.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/photo_5051033548038540506_x-1-1.jpg\",\"width\":700,\"height\":658},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/retatrutide-40mg\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/europepharmacy.eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop\",\"item\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Retatrutide 40MG\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/#website\",\"url\":\"https:\\\/\\\/europepharmacy.eu\\\/\",\"name\":\"European Pharmacy\",\"description\":\"Order Medication &amp; Pills Online\",\"publisher\":{\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/europepharmacy.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/#organization\",\"name\":\"European Pharmacy\",\"url\":\"https:\\\/\\\/europepharmacy.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/europepharmacy.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/WhatsApp-Image-2026-09-07-at-18.41.53.jpeg\",\"contentUrl\":\"https:\\\/\\\/europepharmacy.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/WhatsApp-Image-2026-09-07-at-18.41.53.jpeg\",\"width\":1254,\"height\":1254,\"caption\":\"European Pharmacy\"},\"image\":{\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Retatrutide 40MG","description":"Retatrutide 40MG Retatrutide is an investigational triple-agonist drug (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly for obesity","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/europepharmacy.eu\/it\/shop\/retatrutide-40mg\/","og_locale":"it_IT","og_type":"article","og_title":"Retatrutide 40MG","og_description":"Retatrutide 40MG Retatrutide is an investigational triple-agonist drug (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly for obesity","og_url":"https:\/\/europepharmacy.eu\/it\/shop\/retatrutide-40mg\/","og_site_name":"European Pharmacy","article_modified_time":"2026-09-09T13:13:10+00:00","og_image":[{"width":740,"height":740,"url":"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/04\/photo_5123147599421574210_x.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tempo di lettura stimato":"2 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/europepharmacy.eu\/shop\/retatrutide-40mg\/","url":"https:\/\/europepharmacy.eu\/shop\/retatrutide-40mg\/","name":"Retatrutide 40MG","isPartOf":{"@id":"https:\/\/europepharmacy.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/europepharmacy.eu\/shop\/retatrutide-40mg\/#primaryimage"},"image":{"@id":"https:\/\/europepharmacy.eu\/shop\/retatrutide-40mg\/#primaryimage"},"thumbnailUrl":"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/09\/photo_5051033548038540506_x-1-1.jpg","datePublished":"2026-09-09T13:10:09+00:00","dateModified":"2026-09-09T13:13:10+00:00","description":"Retatrutide 40MG Retatrutide is an investigational triple-agonist drug (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly for obesity","breadcrumb":{"@id":"https:\/\/europepharmacy.eu\/shop\/retatrutide-40mg\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/europepharmacy.eu\/shop\/retatrutide-40mg\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/europepharmacy.eu\/shop\/retatrutide-40mg\/#primaryimage","url":"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/09\/photo_5051033548038540506_x-1-1.jpg","contentUrl":"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/09\/photo_5051033548038540506_x-1-1.jpg","width":700,"height":658},{"@type":"BreadcrumbList","@id":"https:\/\/europepharmacy.eu\/shop\/retatrutide-40mg\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/europepharmacy.eu\/"},{"@type":"ListItem","position":2,"name":"Shop","item":"https:\/\/europepharmacy.eu\/shop\/"},{"@type":"ListItem","position":3,"name":"Retatrutide 40MG"}]},{"@type":"WebSite","@id":"https:\/\/europepharmacy.eu\/#website","url":"https:\/\/europepharmacy.eu\/","name":"European Pharmacy","description":"Order Medication &amp; Pills Online","publisher":{"@id":"https:\/\/europepharmacy.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/europepharmacy.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/europepharmacy.eu\/#organization","name":"European Pharmacy","url":"https:\/\/europepharmacy.eu\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/europepharmacy.eu\/#\/schema\/logo\/image\/","url":"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/09\/WhatsApp-Image-2026-09-07-at-18.41.53.jpeg","contentUrl":"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/09\/WhatsApp-Image-2026-09-07-at-18.41.53.jpeg","width":1254,"height":1254,"caption":"European Pharmacy"},"image":{"@id":"https:\/\/europepharmacy.eu\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/europepharmacy.eu\/it\/wp-json\/wp\/v2\/product\/10302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europepharmacy.eu\/it\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/europepharmacy.eu\/it\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/europepharmacy.eu\/it\/wp-json\/wp\/v2\/comments?post=10302"}],"version-history":[{"count":1,"href":"https:\/\/europepharmacy.eu\/it\/wp-json\/wp\/v2\/product\/10302\/revisions"}],"predecessor-version":[{"id":10367,"href":"https:\/\/europepharmacy.eu\/it\/wp-json\/wp\/v2\/product\/10302\/revisions\/10367"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europepharmacy.eu\/it\/wp-json\/wp\/v2\/media\/10366"}],"wp:attachment":[{"href":"https:\/\/europepharmacy.eu\/it\/wp-json\/wp\/v2\/media?parent=10302"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/europepharmacy.eu\/it\/wp-json\/wp\/v2\/product_brand?post=10302"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/europepharmacy.eu\/it\/wp-json\/wp\/v2\/product_cat?post=10302"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/europepharmacy.eu\/it\/wp-json\/wp\/v2\/product_tag?post=10302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}